Who owns Sana Biotechnology, Inc. (PRAN)? Elite investor 13F holders
4 tracked elite investors reported holding Sana Biotechnology, Inc as of 2026-06-30, including Alphabet, Renaissance Technologies LLC, Tudor Investment, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Alphabet | SANA BIOTECHNOLOGY INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 9815625.00 USD | 2812500.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | SANA BIOTECHNOLOGY INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 4296539.00 USD | 1231100.000000 | Shares | reduce | Original filing |
| Tudor Investment | SANA BIOTECHNOLOGY INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 306743.00 USD | 87892.000000 | Shares | reduce | Original filing |
| D.E. Shaw | SANA BIOTECHNOLOGY INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 139914.00 USD | 40090.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.